The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

 By: Cureus

Introduction: The Clockwork Monster of Multiple Endocrine Neoplasia

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

Multiple EndocrineNeoplasia Type 2A (MEN2A) is an autosomal dominant genetic syndrome that behaves like a slow-motion endocrine time bomb. For clinicians, managing it is less about a single cure and more about lifelong vigilance. The classic triad—Medullary Thyroid Carcinoma (MTC), primary hyperparathyroidism, and pheochromocytoma—presents an aggressive physiological storm.

While primary tumor resections are heavily documented in medical literature, a far more terrifying clinical scenario exists: the metachronous contralateral recurrence. When a pheochromocytoma returns in the remaining adrenal gland years after the first was removed, the patient’s physiological buffering capacity is drastically altered.

This case report details the high-stakes perioperative journey of a 29-year-old female in Pakistan battling a recurrent pheochromocytoma. Her case highlights a profound gap in national literature and serves as a masterclass in multidisciplinary anesthetic precision, meticulous preoperative preparation, and split-second intraoperative crisis management.

 

Case Presentation: The Silent Resurgence

Background and Surgical History

The patient, a 29-year-old woman with a confirmed genetic diagnosis of MEN2A, was no stranger to major endocrine interventions. In 2022, she underwent a successful right adrenalectomy to excise a primary pheochromocytoma, followed closely by a total thyroidectomy and parathyroidectomy to treat medullary thyroid carcinoma.

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

For two and a half years, her life returned to a semblance of normalcy. She was maintained stably on a daily regimen of:

·         Levothyroxine (150 mcg) for thyroid hormone replacement.

·         Vitamin D supplementation for post-parathyroidectomy calcium homeostasis.

The Incidental Discovery

During a routine, asymptomatic endocrine follow-up in late 2024, screening biomarkers sent shockwaves through her medical team. Despite feeling completely fine, her biochemical profile revealed dangerously elevated plasma normetanephrine levels exceeding 760 pg/mL.

An urgent Computed Tomography (CT) scan utilizing an adrenal protocol was ordered. The imaging confirmed a well-circumscribed, $11 \times 15\text{ mm}$ nodule in her left adrenal gland, displaying no signs of internal calcification or hemorrhage. To rule out wider metastatic disease, an advanced functional DOTA-PET scan was performed, revealing a solitary, highly avid lesion restricted entirely to the left adrenal gland. The diagnosis was definitive: a recurrent, contralateral pheochromocytoma.

 

Preoperative Optimization: Taming the Catecholamine Storm

The patient was scheduled for an elective open left adrenalectomy. However, her anesthetichistory carried a glaring red flag: a previous surgical attempt had been abruptly canceled after she experienced a catastrophic, life-threatening hypertensive crisis immediately upon the induction of anesthesia.

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

Resolving the Pharmacological Paradox

To prevent a repeat disaster, the endocrinology and anesthesia teams collaborated to orchestrate a watertight preoperative blockade. The goal was to combat the massive, unpredictable surges of epinephrine and norepinephrine characteristic of pheochromocytomas.

The medical regimen consisted of:

1.      Alpha-Blockade First: Doxazosin (10 mg at bedtime) was titrated to dilate blood vessels and lower systemic vascular resistance.

2.      Beta-Blockade Second: Once alpha-adrenergic receptor saturation was achieved, Metoprolol (25 mg daily) was introduced to control reflex tachyarrhythmias.

Critical Clinical Pearl: Alpha-blockade must always precede beta-blockade. Introducing a beta-blocker first leaves alpha-1 receptors unopposed, allowing circulating catecholamines to trigger a massive, paradoxically fatal hypertensive crisis.

Evaluating Adequacy: The Roizen Criteria Challenge

To assess her readiness for the operating room, the team utilized the classic Roizen Criteria. A perfect candidate must meet four stringent parameters:

·         No in-hospital blood pressure readings $>160/90\text{ mmHg}$ within 24 hours of surgery.

·         The presence of orthostatic hypotension (systolic BP $<80\text{ mmHg}$ or diastolic $<45\text{ mmHg}$ upon standing).

·         No ST- or T-wave ECG abnormalities for a week prior.

·         Fewer than five premature ventricular contractions (PVCs) per minute.

Interestingly, our patient scored a 1 out of 4, manifesting deep orthostatic hypotension. Upon standing, her blood pressure plummeted from $110/70\text{ mmHg}$ to an alarming $60/40\text{ mmHg}$. This extreme fluctuation highlighted the precarious tightrope the team was walking: her system was profoundly alpha-blocked, leaving her with an incredibly fragile intravascular volume and zero catecholamine reserve.

 

Intraoperative Management: Walking the Tightrope

On the morning of the surgery, the anesthesia team prepared for the worst-case scenario. Every syringe of vasoactive medication was mixed, labeled, and primed before the patient even entered the room.

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

       [Fragile Baseline]

               │

               ▼

   [Anesthetic Induction] ──► Risk of Severe Hypotension (Loss of Sympathetic Tone)

               │

               ▼

     [Tumor Manipulation] ──► Risk of Hypertensive Crisis / Arrhythmias

               │

               ▼

      [Tumor Resection]   ──► Risk of Sudden Cardiovascular Collapse

The Induction Phase

Because her previous induction resulted in an aborted surgery, the approach this time was slow, deliberate, and heavily monitored.

·         An invasive arterial line was established under local anesthesia before induction for beat-to-beat blood pressure tracking.

·         Central venous access was secured to provide a dedicated route for rapid-acting vasoactive infusions.

·         Anesthesia was smoothly induced using a tailored cocktail of fentanyl, midazolam, propofol, and atracurium.

·         Sevoflurane was selected for maintenance due to its excellent hemodynamic stability and minimal potential to cause arrhythmias.

To blunt the sympathetic surge of endotracheal intubation, 2 grams of Magnesium Sulfate ($\text{MgSO}_4$) were administered at induction alongside 100 mg of Hydrocortisone to preemptively ward off acute adrenal insufficiency.

Tumor Manipulation vs. Resection

During the open dissection, the surgical team moved with extreme care. Because the patient’s alpha-blockade was so robust, the anticipated intraoperative hypertensive spikes during tumor handling never fully materialized. Instead, the primary challenge shifted to maintaining a viable mean arterial pressure.

A low-dose noradrenaline (norepinephrine) infusion was initiated early and carefully titrated alongside crystalloid fluid boluses. The moment the adrenal veins were clamped and the tumor was fully excised, the sudden withdrawal of circulating catecholamines threatened to plunge the patient into profound shock. However, because the noradrenaline infusion was already active, the drop was anticipated, caught, and smoothly corrected.

 

Postoperative Recovery and Outcomes

Following the successful removal of the tumor, the noradrenaline infusion was safely tapered off as the patient’s intrinsic hemodynamic mechanisms stabilized.

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

For postoperative pain management—a critical factor in preventing delayed sympathetic surges—an epidural infusion of 0.125% bupivacaine at 10 mL/hour was established. The neuromuscular blockade was reversed, and the patient was successfully extubated right on the operating room table. She transitioned to the Post-Anesthesia Care Unit (PACU) with perfectly stable vitals, experiencing a completely uneventful recovery and subsequent discharge.

 

Discussion: What This Case Teaches Us

The Metachronous MEN2A Conundrum

Bilateral adrenal involvement is a defining, hereditary hallmark of MEN2A-associated pheochromocytomas, occurring in up to 50% of patients. What makes this case uniquely challenging is its metachronous nature—the tumors appeared years apart.

The Shadow of MEN2A: Navigating the High-Stakes Anesthetic Minefield of Recurrent Pheochromocytoma

When a patient undergoes a secondary, contralateral adrenalectomy, they lose their remaining natural source of endogenous catecholamines and glucocorticoids. Thephysiological buffer is entirely gone.

The Role of the Multidisciplinary Team (MDT)

The flawless outcome of this high-risk procedure was not a fluke; it was the direct result of an active Multidisciplinary Team (MDT) framework.

Specialty	Primary Responsibility in MEN2A Management
Endocrinology	Long-term biochemical screening, precise alpha/beta titration, and lifelong hormone replacement charting.
Radiology	Dual-modality tracking (Adrenal CT protocol + DOTA-PET functional imaging) for micro-nodule localization.
Anesthesiology	Advanced invasive monitoring, pre-induction arterial line mapping, pharmacological blunting of intubation surges, and vasoactive titration.
Endocrine Surgery	Gentle, low-impact tissue manipulation to minimize mechanical catecholamine release during open dissection.

---

Conclusion: Key Clinical Takeaways

This case reinforces several immutable laws of endocrine anesthesia:

·         Never rely on a lack of symptoms: A patient can be entirely asymptomatic with completely normal baseline blood pressures, yet harbor a biochemical powder keg. Lifelong plasma normetanephrine screening is mandatory in MEN2A.

·         Respect the Roizen Criteria: Orthostatic hypotension is a valuable sign of successful alpha-blockade, but it warns the anesthesiologist that the patient will be highly sensitive to the vasodilatoryeffects of induction agents.

·         Always Be Prepared for the Drop: The true danger in a thoroughly alpha-blocked patient often isn't the hypertensive spike during tumor manipulation—it is the catastrophic cardiovascular collapse that occurs the exact second the tumor's venous drainage is cut off.

Ultimately, this 29-year-old patient’s triumph proves that even when dealing with the unpredictable physiology of MEN2A, meticulous planning and cross-specialty collaboration can turn a high-stakes clinical minefield into a routine, safe, and successful operation.